​

NervGen Pharma Ownership | Who Owns NervGen Pharma?


OverviewChart

NervGen Pharma Ownership Summary


NervGen Pharma is owned by 12.97% institutional investors, 15.56% insiders, and 71.46% retail investors. Valley forge investment consultants inc adv is the largest institutional shareholder, holding 0.90% of NGEN shares. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.06% of its assets in NervGen Pharma shares.

NGEN Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockNervGen Pharma12.97%15.56%71.46%
SectorHealthcare Stocks 247.07%12.15%-159.22%
IndustryBiotech Stocks 385.89%11.79%-297.68%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Valley forge investment consultants inc adv834.16K0.90%$1.59M
Marshall wace, llp617.25K0.67%$1.18M
Ubs group284.57K0.31%$543.53K
Pfg investments242.50K0.26%$463.18K
Royal bank of canada171.96K0.24%$648.00K
Stonepine capital management200.00K0.22%$382.00K
Integrated wealth concepts86.81K0.12%$327.29K
Bank of montreal /can/70.07K0.08%$133.83K
Geode capital management67.45K0.07%$128.83K
Captrust financial advisors65.42K0.07%$124.95K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Valley forge investment consultants inc adv834.16K0.39%$1.59M
Stonepine capital management200.00K0.24%$382.00K
Disciplined investors51.00K0.04%$97.41K
Pfg investments242.50K0.02%$463.18K
Axq capital, lp49.13K0.01%$93.84K
Patriot financial group insurance agency37.00K0.01%$139.49K
Mckinley carter wealth services30.89K0.01%$116.46K
Almanack investment partners, llc.25.60K0.01%$48.90K
Liberty wealth management22.00K0.00%$42.02K
Moors & cabot42.26K0.00%$80.71K

Top Buyers

HolderShares% AssetsChange
Valley forge investment consultants inc adv834.16K0.39%824.16K
Marshall wace, llp617.25K0.00%181.29K
Royal bank of canada171.96K0.00%171.96K
Integrated wealth concepts86.81K0.00%86.81K
State street61.30K-61.30K

Top Sellers

HolderShares% AssetsChange
Jane street group40.70K--230.05K
Quadrature capital---134.52K
Ubs group284.57K0.00%-95.15K
Stonepine capital management200.00K0.24%-71.68K
Hrt financial lp15.88K0.00%-27.97K

New Positions

HolderShares% AssetsChangeValue
Royal bank of canada171.96K0.00%171.96K$648.00K
Integrated wealth concepts86.81K0.00%86.81K$327.29K
State street61.30K-61.30K$117.08K
United capital financial advisers54.65K0.00%54.65K$104.39K
Disciplined investors51.00K0.04%51.00K$97.41K

Sold Out

HolderChange
Simplex trading-27.00
Mai capital management-700.00
Cibc world market-10.96K
Quadrature capital-134.52K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20266544.44%11,993,602608.28%12288.86%42-4.55%7-
Mar 31, 202630-856,019-1-30---
Mar 31, 20241-3,400--17368.42%----
Dec 31, 20231-3,400--17487.72%----
Sep 30, 20231-3,400--17484.21%----

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Nasdaq Composite Index67.45K0.06%-
State Street® SPDR® S&P® Intl Sm Cp ETF61.61K0.06%-
iShares Neuroscience and Healthcare ETF8.26K0.01%-

Recent Insider Transactions


DateNameRoleActivityValue
Oct 27, 2006Dreismann Heiner-Buy$15.82K
Oct 27, 2006Dreismann Heiner-Buy$48.75K
Aug 01, 2005BIRNDORF HOWARD C Executive Chairman and CEOSell$55.90K
Aug 01, 2005BIRNDORF HOWARD C Executive Chairman and CEOSell$55.04K
Jul 11, 2005BIRNDORF HOWARD C Executive Chairman and CEOSell$50.88K

NGEN Ownership FAQ


Who Owns NervGen Pharma?

NervGen Pharma shareholders are primarily institutional investors at 12.97%, followed by 15.56% insiders and 71.47% retail investors. The average institutional ownership in NervGen Pharma's industry, Biotech Stocks , is 385.89%, which NervGen Pharma falls below.

Who owns the most shares of NervGen Pharma?

NervGen Pharma’s largest shareholders are Valley forge investment consultants inc adv (834.16K shares, 0.90%), Marshall wace, llp (617.25K shares, 0.67%), and Ubs group (284.57K shares, 0.31%). Together, they hold 1.88% of NervGen Pharma’s total shares outstanding.

Does Blackrock own NervGen Pharma?

BlackRock is not among the top 10 institutional shareholders of NervGen Pharma.

Who is NervGen Pharma’s biggest shareholder by percentage of total assets invested?

Valley forge investment consultants inc adv is NervGen Pharma’s biggest shareholder by percentage of total assets invested, with 0.39% of its assets in 834.16K NervGen Pharma shares, valued at 1.59M$.

Who is the top mutual fund holder of NervGen Pharma shares?

Fidelity Nasdaq Composite Index is the top mutual fund holder of NervGen Pharma shares, with 0.06% of its total shares outstanding invested in 67.45K NervGen Pharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools